What is a gonorrhea test? Gonorrhea is one of the most common sexually transmitted diseases (STDs). It is a bacterial infection spread through vaginal, oral, or anal sex with an infected person. It can also be spread from a pregnant woman to her baby during childbirth. Gonorrhea can infect both men and women. It is […]Continue Reading ...
WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) — Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced that The New England journal of Medicine (NEJM) published results from a Phase 2 clinical trial evaluating the safety and efficacy of zoliflodacin in patients with uncomplicated gonorrhea. […]Continue Reading ...
An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, sponsored […]Continue Reading ...
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance. BUSM researchers (in collaboration with University of Toronto researchers) have been investigating the use of animal models of gonorrhea, to study how the infection evolves and for potential use to determine the efficacy […]Continue Reading ...
July 27, 2018 Critical Discovery Comes as Antibiotic-Resistant ‘Super Gonorrhea’ Spreads Good news in the battle against the growing threat of drug-resistant “super gonorrhea”: Researchers at the University of Virginia School of Medicine and their collaborators in the United Kingdom have discovered a new way that the bacteria that cause gonorrhea resist the body’s immune […]Continue Reading ...
May 16, 2018 The first European-wide genomic survey of gonorrhea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers at The Centre for Genomic Pathogen Surveillance (CGPS), the Wellcome Sanger Institute, European Centre for Disease Control, and their collaborators also showed that using DNA sequencing data they could accurately determine antibiotic […]Continue Reading ...
March 30, 2018 Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years. Gonorrhea is caused […]Continue Reading ...
A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new antibiotic effectively treats uncomplicated urogenital and rectal gonorrhea infections in a single oral dose. Results are published in the November […]Continue Reading ...
TUESDAY, Sept. 4, 2018 — Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, marking a fourth consecutive year of sharp increases in these sexually transmitted diseases (STDs), according to a report published by the U.S. Centers for Disease Control and Prevention. Based on preliminary data for […]Continue Reading ...
Neisseria gonorrhea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin […]Continue Reading ...
May 17, 2018 Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance program for sexually transmitted infections shows distribution of drug-resistant gonorrhea strains across Europe. The study results are […]Continue Reading ...
CARB Fact Sheet (February 15, 2018) Gonococcal Isolate Surveillance Project (GISP) Profiles 2015 (June 1, 2017) AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation. Blog by NCHHSTP Director: What Healthcare Providers Can Do to Slow Gonorrhea’s Growing Resistance to First-line Antibiotics Combating the […]Continue Reading ...
WEDNESDAY, April 4, 2018 — Americans should expect that a super-resistant form of gonorrhea like that found in the United Kingdom will soon reach these shores, health experts say. Earlier this year, doctors diagnosed a man in England with a case of gonorrhea that could not be cured with antibiotics commonly deployed against the sexually […]Continue Reading ...
A man from United Kingdom has acquired a gonorrhea infection with bacteria that is resistant to most antibiotics used commonly against it. The man has a regular sexual partner but picked up this superbug from a sexual encounter with a partner in south-east Asia earlier this year.Continue Reading ...
- Study identifies how hantaviruses infect lung cells
- Improving PTSD care through genetics
- Dermatology providers show interest in recommending cannabinoids to patients
- Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression
- Four dried fruits have lower glycemic index than starchy foods, study finds
- Optimization of drug dose sizes can reduce pharmaceutical wastage
- Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed
- PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds
- Researchers aim to identify and target high blood pressure indicators
- Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows
- One implant, two prices. It depends on who’s paying.
- Standardizing feeding practices improves growth trends for micro-preemies
- COPD Tied to Obesity in Male, Female Never-Smokers
- Flossing: Information for Caregivers
- Does breastfeeding hormone protect against type 2 diabetes?
- Educating future doctors to prescribe physical activity for their patients
- Krystal 2000 microplate design improves fluorescence and luminescence measurement
- FDA clears mobile medical app to help increase retention in recovery program for opioid use disorder
- Overcoming Challenges in High-Speed Centrifugation Experiments
- Study shows link between neighborhoods’ socioeconomic status and dietary choices